BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25689647)

  • 1. A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting.
    Underhill ML; Chicko L; Berry DL
    Clin J Oncol Nurs; 2015 Feb; 19(1):38-40. PubMed ID: 25689647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nurse-led multidomain intervention to improve the management of chemotherapy-induced nausea and vomiting in patients with head and neck cancers: A randomized controlled trial.
    Cao J; Chen C; Wang Y; Liu M; Han X; Li H
    Eur J Oncol Nurs; 2024 Jun; 70():102615. PubMed ID: 38797114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malnutrition and chemotherapy-induced nausea and vomiting: implications for practice.
    Davidson W; Teleni L; Muller J; Ferguson M; McCarthy AL; Vick J; Isenring E
    Oncol Nurs Forum; 2012 Jul; 39(4):E340-5. PubMed ID: 22750904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
    ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey.
    Krishnasamy M; Kwok-Wei So W; Yates P; de Calvo LE; Annab R; Wisniewski T; Aranda S
    Cancer Nurs; 2014; 37(4):E27-35. PubMed ID: 24145248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
    Wickham R
    J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
    Viale PH; Grande C; Moore S
    Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevention of nausea and vomiting induced by antineoplastic chemotherapy: the state of the art].
    Roila F; Tonato M; Del Favero A
    Riv Inferm; 1991; 10(1):40-3. PubMed ID: 1853098
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
    Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective interventions for CINV: NCCN Antiemesis Clinical Practice Guidelines in Oncology.
    ONS News; 2004; 19(9 Suppl):17-8. PubMed ID: 15478570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and management of chemotherapy-induced nausea and vomiting.
    Moradian S; Howell D
    Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a simple diary for management of nausea and vomiting during chemotherapy.
    Barak F; Amoyal M; Kalichman L
    Clin J Oncol Nurs; 2013 Oct; 17(5):479-81. PubMed ID: 24080046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States.
    Craver C; Gayle J; Balu S; Buchner D
    J Med Econ; 2011; 14(1):87-98. PubMed ID: 21241160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy induced nausea and vomiting: a European perspective.
    Vidall C
    Br J Nurs; 2011 May 27-Jun 9; 20(10):S22, S25-8. PubMed ID: 21647008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.